23 November 2024

Howe Street Reporter Title

Tag: trading

  • Is it time to go long Natural Gas?

    Is it time to go long Natural Gas?

    From a technical analysis perspective, it appears as if natural gas has bottomed. Is it now time to go long natural gas? I am approaching this from a trading/medium term perspective. From a long term/investing perspective I do believe natural gas has a promising future. Liquified natural gas (LNG) has been making recent headlines given…

  • Skyharbour Resources (SYH.V) approaches major support as uranium looks to breakout

    Skyharbour Resources (SYH.V) approaches major support as uranium looks to breakout

    *originally published November 23, 2022 We here at Equity Guru are big fans of uranium. The commodity is still up 7% for the year, but could be on the verge of making another large run taking us back to the highs of 2022 and above. In my most recent uranium weekly sector roundup, I discussed…

  • Tier One Silver (TSLV.V) bonanza grades at projects with untapped potential!

    Tier One Silver (TSLV.V) bonanza grades at projects with untapped potential!

    With the Vancouver Resource Investment Conference (VRIC 2023) coming up in a few days, my pre-conference routine has begun. Whenever I attend any mining conference, the first thing I do is go over the technical charts of every single company. I look for setups which meet my bottoming and reversal criteria and then save them…

  • Medexus Pharmaceuticals (MDP.TO): A growing core business breaking company records

    Medexus Pharmaceuticals (MDP.TO): A growing core business breaking company records

    *originally published 01-16-23 Medexus Pharmaceuticals (MDP.TO) is a specialty pharma company. They are not biotech. There is no research and development here. Medexus is all about sales and marketing, bringing over drugs that are already licensed in Western Europe and then bringing them to North America. A very smart business model which has seen Medexus carve…

  • Gold markets are on fire, a week away from VRIC 2023

    Gold markets are on fire, a week away from VRIC 2023

    With the beginning of a new year, I look forward to Cambridge House’s Vancouver Resource Investment Conference. A conference which has played a major part in my investing/trading career. It was the first ever financial conference I attended way back in the day when I was a young man. At that time, I was one…

  • The bottom for gold stocks? 3 gold stocks ready for a major move!

    The bottom for gold stocks? 3 gold stocks ready for a major move!

    Gold prices are rallying as the US Dollar falls. Technically, the dollar is holding a range, so more work is required on the charts before we can confirm a major dollar reversal. If this happens (although many would say when!) we can safely say gold is ready to reverse. Gold tested $1620 for the third…

  • Yensanity! Why the Bank of Japan matters!

    Yensanity! Why the Bank of Japan matters!

    Months ago, I warned readers that the Bank of Japan is the most important central bank to be watching. I even did a video explaining why every trader must be watching the Bank of Japan (BoJ). Nobody really cared much about the BoJ since their monetary policy meetings never changed. But things could be changing.…

  • NioCorp (NB.T) is developing the next niobium mine!

    NioCorp (NB.T) is developing the next niobium mine!

    If you want to invest in something with a bold geopolitical flavor, then rare earth minerals are the investment for you. When the China trade war headlines were all the markets were talking about way back when, rare earth minerals were always in articles titled something along the lines of, “Possible China trade war weapons”.…

  • Medexus Pharmaceuticals (MDP.TO) Q2 2023 revenue expected to exceed US$27 million

    Medexus Pharmaceuticals (MDP.TO) Q2 2023 revenue expected to exceed US$27 million

    Medexus Pharmaceuticals (MDP.TO) is a specialty pharma company that has been making big moves on the charts. The company is not a biotech company. They do not do research and development, but instead bring over drugs that are already licensed in Western Europe to North America which sees them carve out a nice and profitable…

  • Brace yourself! A major central bank week is ahead!

    Brace yourself! A major central bank week is ahead!

    As markets still feel the pain after last week’s worst sell off since 2020, more volatility is ahead. As a technical analyst, many charts which will determine where stocks go are either at major support or at resistance. Hopeful for a turnaround but that will depend on the fundamental catalyst. It is a major central…